APA (7th ed.) Citation

Shi, X., Fan, J., Pei, X., Wang, Y., Guo, G., Yang, T., . . . Li, L. (2021). Inflammatory factor‐based prognostic risk stratification for patients with metastatic castration‐resistant prostate cancer treated with docetaxel. Andrologia, 53(6), 1. https://doi.org/10.1111/and.14064

Chicago Style (17th ed.) Citation

Shi, Xinyu, Junjie Fan, Xinqi Pei, Yuzhao Wang, Guodong Guo, Tao Yang, Xinyang Wang, Dalin He, and Lei Li. "Inflammatory Factor‐based Prognostic Risk Stratification for Patients with Metastatic Castration‐resistant Prostate Cancer Treated with Docetaxel." Andrologia 53, no. 6 (2021): 1. https://doi.org/10.1111/and.14064.

MLA (9th ed.) Citation

Shi, Xinyu, et al. "Inflammatory Factor‐based Prognostic Risk Stratification for Patients with Metastatic Castration‐resistant Prostate Cancer Treated with Docetaxel." Andrologia, vol. 53, no. 6, 2021, p. 1, https://doi.org/10.1111/and.14064.